INFORMATION FOR
William Paterson University assistant professor of biology Christopher Mayack is a co-investigator on a national, FDA-funded research initiative aimed at developing new treatments for diseases threatening honeybee populations, which play a critical role in pollinating crops and sustaining the nation's food supply.
Mayack is part of a five-year project led by the University of California, Davis, through its Innovation Center for Honey Bee Therapeutics and Regulatory Science. The U.S. Food and Drug Administration (FDA) is providing $999,756 in first-year funding for the initiative, which will employ AI-assisted drug discovery, laboratory testing, and regulatory research to accelerate the development and approval of treatments for major honeybee diseases.
At William Paterson, the research will make use of the University's rooftop apiary at Science Hall West, which Mayack jointly manages with biology professor David Gilley. Mayack and a team of students will screen 400 FDA-approved drugs to identify existing medications that could be repurposed to combat Nosema ceranae, a parasite that infects the digestive systems of honeybees.
The team will also analyze drug residues in bees and hive products, including honey, pollen, and beeswax, following field testing of promising treatments for four major honeybee diseases. These analyses will help determine whether the treatments leave behind residues that could pose health risks to people who consume honey and other bee products, a critical step toward securing regulatory approval for their use.
According to Mayack, honeybees help pollinate approximately one-third of the food people consume, including many fruits, vegetables, and nuts. He notes that annual colony losses can reach 50 to 60 percent, with disease among the contributing factors. Because honeybees are highly managed, they have limited opportunities to develop natural resistance to introduced diseases, making the need for effective treatments especially urgent.
"The main bottleneck is regulatory approval for getting a new honeybee drug to market and into the hands of beekeepers," Mayack explains. "With the help of the FDA, we hope to establish guidelines for that process and accelerate the discovery of new treatments. Getting these drugs approved and into use is the only way to make a real large-scale impact on improving honeybee health."
The five-year project will provide hands-on research opportunities for seven William Paterson students—five undergraduates and two graduate students—including two who will pursue related work through their Honors College theses. Graduate and Honors students will take leading roles in various aspects of the research.